Avidity Biosciences commands a market capitalization valuation of approximately eleven billion US dollars (or exceeding one trillion Indian Rupees equivalent), reflecting its significant standing in the global biopharmaceutical sector. Its total enterprise value and financial net worth have expanded dramatically following major strategic corporate transactions, clinical trial milestones, and high-profile acquisition agreements by multinational pharmaceutical giants valuing its proprietary drug delivery platforms and specialized neuroscience pipeline assets.